Skip to content
★ Sign in to follow
RA

Reuven Avital

Executive
Navidea Biopharmaceuticals, Inc.
Total declarations
10
Company
1
▲ Purchases (10 ops.)
€88k
▼ Sales (0 ops.)
—

Latest filing published 18 Mar 2010 for Navidea Biopharmaceuticals, INC., €15k.

Insider track record

Disclosed buys
10
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
10

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Reuven Avital: trading record in brief

Reuven Avital discloses dealings in Navidea Biopharmaceuticals, Inc. to SEC (Form 4). The record holds 10 filings, for trades running from 7 August 2008 to 16 March 2010.

On the market, this insider has only ever bought: 10 purchases, €88k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2010 to date brings 1 purchase and no sales.

A typical purchase (the median) is worth €9,785.

The record was last updated on 18 March 2010 with an open-market purchase (€15k) in Navidea Biopharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Reuven Avital

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total

10 of 10 declarations